Integral Health Asset Management’s Zymeworks ZYME Stock Holding History

Integral Health Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,000	Closed	-$1.45M	–	85
2021 Q3	$1.45M	Buy	+50,000	New	+$1.66M	0.42%	59
2020 Q1	–	Sell	-65,000	Closed	-$2.96M	–	76
2019 Q4	$2.96M	Buy	+65,000	New	+$2.36M	1.15%	30

Other funds holding ZYME

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Integral Health Asset Management's ZYME Position: Q4 2021 in Review

Integral Health Asset Management sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 50,000 shares — an estimated $1.45M sold.

Integral Health Asset Management first reported a position in ZYME in Q4 2019 and held it in 2 quarters. The position peaked at $2.96M in Q4 2019. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.

Integral Health Asset Management reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
Integral Health Asset Management sold 50,000 Zymeworks shares in Q4 2021, an estimated $1.45M.
Integral Health Asset Management first reported a position in Zymeworks in Q4 2019 and held it in 2 quarters.
Integral Health Asset Management's Zymeworks position peaked at $2.96M in Q4 2019.
114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.

Based on Integral Health Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.